FRACTOR DAVID 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 11, 2013
Insider Transaction Report
Form 4
FRACTOR DAVID
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2013-03-07−64,000→ 64,000 totalExercise: $2.72Exp: 2020-02-29→ Common Stock (64,000 underlying)
Footnotes (1)
- [F1]The option vests in one annual installment of 16,000 shares on March 1, 2014 and in equal monthly installments for the three years thereafter.